DePuy Hip Implants Recalled Due To High Revision Rates.

DePuy will pay $2.5 B to hip replacement victims

July 8th, 2014

DePuy has waived its “walk-away rights” in a hip replacement settlement and will pay more than $2.5 billion to thousands of patients who were injured by DePuy ASR hip replacements. The decision to waive the rights means the company acknowledged that enough patients have agreed to the settlement.

According to The Journal Gazette, the base pay to patients who suffered injuries from the faulty hip replacements will be $250,000. Johnson & Johnson issued a DePuy ASR hip replacement recall in 2010 after nearly 13% of patients who received the device required revision surgery to fix implant complications. More than 100,000 patients worldwide were estimated to have received a DePuy hip implant.

DePuy metal-on-metal hip replacements were first approved by the U.S. Food and Drug Administration in 2004. Research soon linked the hip devices to severe complications in patients, including premature loosening of the hip joint, tissue damage, inflammation, limited mobility and toxic levels of metal on the blood stream, or metallosis.

Contact Us Today for a Free Consultation.

I am currently represented by an attorney.
*Required fields